Free
External
Join Sidley and industry leaders from across the globe for this in-person, one-day event in London, with the option to stream and network virtually from outside the UK.
We look forward to incisive content, robust discussion, and valuable networking during a day of looking at the continued combination of innovation and capital driving positive patient outcomes and investment returns.
9am–10am – Pre-conference Transatlantic Life Sciences Regulatory Briefing
10am–6.30pm – Main conference, including networking lunch, followed by networking reception
Join Sidley and industry leaders from across the globe, including from Advanz Pharma, Astorg, AstraZeneca, Clinton Foundation, Clinton Health Access Initiative, Financial Times, Graviton Bioscience, Harbinger Health, Ionctura, J.P. Morgan, LetterOne Health, Lilly Ventures, Merck KGaA, Mestag Therapeutics, Morgan Stanley, Novo Holdings, Oppenheimer & Co. Inc, Ovid Therapeutics, Oxford Science Enterprises, Rothschild & Co, Syncona, and Teva Pharmaceuticals for this in-person, all-day event. Virtual attendance is available to those outside the UK.
Panels will include:
- Private Equity – Investing in Healthcare in Turbulent Markets
- “The Success Journey” – Prominent Biotech CEOS Who Have Achieved Outsize Success Discuss Their Winning Formula
- “View From the Banks” – The Year Passed, and To Come, in Healthcare Dealmaking
- The Pharma Business Development Environment – Opinions, Insights, and Predictions From Leading Dealmakers
- Venture/Growth Capital – How Do Leading Investors View The Current Market? How Do Investors Stand Out?
